EXHIBIT 31.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             As Adopted Pursuant to
                  Section 302 of the Sarbanes-Oxley Act of 2002

      I, Michael Braunold, certify that:

1.    I have reviewed this annual report on Form 10-KSB of SPO Medical Inc.;

2.    Based on my knowledge,  this report does not contain any untrue  statement
      of a material fact or omit to state a material fact  necessary to make the
      statements made, in light of the circumstances under which such statements
      were made,  not  misleading  with  respect  to the period  covered by this
      report;

3.    Based on my  knowledge,  the  financial  statements,  and other  financial
      information  included  in this  report,  fairly  present  in all  material
      respects the financial condition,  results of operations and cash flows of
      the small  business  issuer as of, and for, the periods  presented in this
      report;

4.    I am responsible for establishing and maintaining  disclosure controls and
      procedures (as defined in Exchange Act Rules  13a-15(e) and 15d-15(e)) and
      internal  control  over  financial  reporting  (as defined in Exchange Act
      Rules 13a-15(f) and 15d-15(f)) for the small business issuer and I have:

      (a)  Designed  such  disclosure  controls and  procedures,  or caused such
disclosure  controls and  procedures  to be designed  under my  supervision,  to
ensure  that  material  information  relating  to  the  small  business  issuer,
including its  consolidated  subsidiaries,  is made known to me by others within
those  entities,  particularly  during the period in which this  report is being
prepared;

      (b) Evaluated the effectiveness of the small business issuer's  disclosure
controls and procedures  and presented in this report my  conclusions  about the
effectiveness  of the disclosure  controls and procedures,  as of the end of the
period covered by this report based on such evaluation; and

      (c)  Disclosed  in this report any change in the small  business  issuer's
internal  control  over  financial  reporting  that  occurred  during  the small
business issuer's most recent fiscal quarter (the small business issuer's fourth
fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially  affect, the small business issuer's internal
control over financial reporting; and

5.    I have disclosed,  based on my most recent  evaluation of internal control
over financial reporting,  to the small business issuer's auditors and the audit
committee  of the  small  business  issuer's  board  of  directors  (or  persons
performing the equivalent functions):

      (a) All significant  deficiencies and material weaknesses in the design or
operation of internal  controls which could adversely  affect the small business
issuer's   ability  to  record,   process,   summarize   and  report   financial
information;; and

      (b) Any fraud, whether or not material,  that involves management or other
employees who have a significant  role in the small business  issuer's  internal
control over financial reporting.

Date: June 21, 2005

/s/ Michael Braunold
--------------------------------
Michael Braunold
Chief Executive Officer (and
Principal Financial Officer)